Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers
Cardiac involvement in familial transthyretin (TTR) amyloidosis is of major prognostic value, and the development of early-diagnostic tools that could trigger the use of new disease-modifying treatments is crucial. The aim of our study was to compare the respective contributions of 99mTc-diphosphonate scintigraphy (DPD, detecting amyloid deposits) and 123I-MIBG (MIBG, assessing cardiac sympathetic denervation) in patients with genetically proven TTR mutation referred for the assessment of cardiac involvement.
We prospectively studied 75 consecutive patients (classified as symptomatic or asymptomatic carriers), using clinical evaluation, biomarkers (troponin and BNP), echocardiography, and nuclear imaging. Patients were classified as having normal heart-to-mediastinum (HMR) MIBG uptake ratio 4 h after injection (defined by HM4 ≥ 1.85) or abnormal HM4 < 1.85, and positive DPD uptake (grade ≥ 1 of Perugini classification) or negative DPD uptake.
Among 75 patients, 49 (65%) presented with scintigraphic sympathetic cardiac denervation and 29 (39%) with myocardial diphosphonate uptake. When MIBG was normal, DPD was negative except for two patients. Age was an independent predictor of abnormal scintigraphic result of both MIBG and DPD (HR 1.08 and 1.15 respectively), whereas echocardiographic-derived indicators of increased left ventricular filling pressure (E/e’ ratio) was an independent predictor of abnormal MIBG (HR 1.33) and global longitudinal strain of positive DPD (HR 1.45). In asymptomatic patients (n = 31), MIBG was abnormal in 48% (n = 15) among whom 50% had a normal DPD; all those with a normal MIBG (n = 16) had a normal DPD.
In TTR mutation carriers, cardiac sympathetic denervation evidenced by decreased MIBG uptake is detected earlier than amyloid burden evidenced by DPD. These results raise the possibility of a diagnostic role for MIBG scintigraphy at an early stage of cardiac involvement in TTR-mutated carriers, in addition to its well-established prognostic value.
KeywordsAmyloidosis Transthyretin Cardiac amyloidosis MIBG scintigraphy Diphosphonate scintigraphy
This study has been supported by the Association Française Contre l’Amylose.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 10.Algalarrondo V, Piekarski E, Eliahou L, Le Guludec D, Slama MS, Rouzet F. Can nuclear imaging techniques predict patient outcome and guide medical management decisions in hereditary transthyretin cardiac amyloidosis? Curr Cardiol Rep. In press.Google Scholar
- 11.Minutoli F, Di Bella G, Mazzeo A, Donato R, Russo M, Scribano E, et al. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol. 2013;200(3):W256–65.CrossRefPubMedGoogle Scholar
- 13.Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442–8.CrossRefPubMedGoogle Scholar
- 14.Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2011;38(3):470–8.CrossRefPubMedGoogle Scholar
- 28.Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, et al. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid. 2014;21(1):35–44.CrossRefPubMedGoogle Scholar
- 29.Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis. Circ J. 2016;80(9):1998–2003.CrossRefPubMedGoogle Scholar
- 30.Moore PT, Burrage MK, Mackenzie E, Law WP, Korczyk D, Mollee P. The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience. Heart Lung Circ. 2017; https://doi.org/10.1016/j.hlc.2016.12.017.
- 37.Le Guludec D, Delforge J, Dolle F. Imaging the parasympathetic cardiac innervation with PET. In: Slart R, Tio R, Elsinga P, Schwaiger M, editors. Autonomic innervation of the heart. Berlin: Springer; 2015.Google Scholar
- 42.Algalarrondo V, Eliahou L, Thierry I, Bouzeman A, Dasoveanu M, Sebag C, et al. Circadian rhythm of blood pressure reflects the severity of cardiac impairment in familial amyloid polyneuropathy. Arch Cardiovasc Dis. 2012 May;105(5):281–90. https://doi.org/10.1016/j.acvd.2012.03.004.CrossRefPubMedGoogle Scholar
- 48.Chaves M, Bettini M, Marciano S, Sáez S, Cristiano E, Rugiero M. Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina. Medicina (B Aires). 2016;76(2):105–8.Google Scholar
- 49.Zou X, Dong F, Zhang S, Tian R, Sui R. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor. Exp Eye Res. 2013; https://doi.org/10.1016/j.exer.2013.02.005.
- 50.Meng LC, Lyu H, Zhang W, Liu J, Wang ZX, Yuan Y. Hereditary transthyretin amyloidosis in eight Chinese families. Chin Med J. 2015; https://doi.org/10.4103/0366-6999.168048.